Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{154657,
        author = {Geetanjali Tambe and H.J.Pagar and NehaTongire and Snehal Jogdand},
        title = {EVALUATION OF EMERGING IN-VITRO ASSAYS IN CERVICAL CANCER},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {8},
        number = {12},
        pages = {47-52},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=154657},
        abstract = {Cervical cancer is one of the most common types of gynaecological cancer in women. It's also one of the most frequent cancers in women, and it's one of the few that may be detected and treated entirely at the precancerous stage. Cervical cancer is caused mostly by sexually transmitted diseases (STDs), as well as the Human Papillomavirus (HPV), particularly HPV-16 and HPV-18. In India, it is still a big public health issue for women. Cervical cancer strikes women between the ages of 55 and 59, and a large percentage of those diagnosed are in advanced stages of the disease. Cervical cancer vaccinations include prophylactic vaccines against HPV-16 and 18 therapeutic v. Premature sexual activity, teen pregnancy, family history, and oral contraceptives are all epidermal risk factors. This page discusses the history of cervical cancer, histological types, risk factors, prevention, therapy, and drugs approved to prevent cervical cancer. Squamous cell carcinoma is the most frequent kind of cervical cancer. Only persons who have never been infected with HPV benefit from the vaccines.},
        keywords = {Cervical cancer, human papillomavirus, prevention},
        month = {},
        }